Sangui Biotech International, Inc. reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported revenue was USD 0.041029 million compared to USD 0.01856 million a year ago. Net income was USD 0.023232 million compared to net loss of USD 0.026909 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 EUR | -20.00% | -.--% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 450K | |
+16.59% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.12% | 30.74B | |
-8.64% | 26.03B | |
+11.81% | 25.92B | |
+45.08% | 14.13B | |
+32.85% | 12.73B | |
-7.19% | 11.29B |
- Stock Market
- Equities
- SBH Stock
- News Sangui Biotech International, Inc.
- Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022